Results 21 to 30 of about 434,643 (342)

Recent asthma exacerbations: A key predictor of future exacerbations [PDF]

Respiratory Medicine, 2007
The objective of this analysis was to investigate whether patients with severe or difficult-to-treat asthma who experienced recent severe asthma exacerbations are at increased risk of future asthma exacerbations.We conducted a 1.5-year prospective analysis of 2780 patients 12 > or =years of age from The Epidemiology and Natural History of Asthma ...
Miller, Mary K., Lee, June H., Miller, Dave P., Wenzel, Sally E.   +3 more
openaire   +2 more sources

Comparative Effectiveness of Step-up Therapies in Children with Asthma Prescribed Inhaled Corticosteroids : A Historical Cohort Study [PDF]

, 2017
This work was supported by the Respiratory Effectiveness Group. Acknowledgments We thank the Respiratory Effectiveness Group for funding this work, Annie Burden for assistance with statistics, and Simon Van Rysewyk and Lisa Law for assistance with ...
Murray, Claire S., Price, David B., Richardson, Kathryn, Thomas, Mike, Turner, Steve W.   +4 more
core   +2 more sources

Single-inhaler fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol plus umeclidinium using two inhalers for chronic obstructive pulmonary disease: A randomized non-inferiority study [PDF]

, 2018
Background: Single-inhaler fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) 100/62.5/25 μg has been shown to improve lung function and health status, and reduce exacerbations, versus budesonide/formoterol in patients with chronic obstructive ...
Birk, Ruby, Brealey, Noushin, Bremner, Peter R, Ismaila, Afisi S, Lipson, David A, Zhu, Chang-Qing   +5 more
core   +2 more sources

Risk factors for exacerbations and pneumonia in patients with chronic obstructive pulmonary disease: a pooled analysis. [PDF]

, 2020
BACKGROUND: Patients with chronic obstructive pulmonary disease (COPD) are at risk of exacerbations and pneumonia; how the risk factors interact is unclear.
A Anzueto, B Majed, C Crim, C Crim, C Crim, CR Simpson, DB DiBardino, DB Rubin, DE Niewoehner, DT Phung, EF Wouters, FJ Martinez, Global Initiative for Chronic Obstructive Lung Disease, GS Collins, GT Ferguson, H Müllerova, H Müllerova, J Kim, J Vestbo, J Zhang, JA Wedzicha, JR Hurst, KM Kew, M Hamer, MB Drummond, MC Harpsøe, MI Restrepo, MT Dransfield, MT García Sanz, P Calverley, P Ernst, PM Calverley, RL DiSantostefano, RL DiSantostefano, S Siederer, S Singh, SD Neidich, SH Lin, SJ Pascoe, WM Chatila, Y Çolak, Y-F Wei, YS Jo   +42 more
core   +2 more sources

Inhaled corticosteroids versus long-acting beta -agonists for chronic obstructive pulmonary disease (Review). [PDF]

, 2011
Long-acting beta(2)-agonists and inhaled corticosteroids can be used as maintenance therapy by patients with moderate to severe chronic obstructive pulmonary disease. These interventions are often taken together in a combination inhaler.
Agarwal, Anderson, Appleton, Barnes, Borgstrom, Borgstrom, Boyd, Burge, Calverley, Calverley, Calverley, Calverley, Calverley, Calverley, Calverley, Calverley, Calverley, Calverley, Calverley, Calverley, Calverley, Calverley, Calverley, Calverley, Calverley, Calverley, Calverley, Calverley, Calverley, Calverley, Calverly, Campbell, Campell, Cazzola, Cazzola, Celli, Celli, Celli, Celli, Corhay, Dahl, Della Cioppa, Egede, Ferguson, Ferguson, Gosman, Greefhorst, Halpin, Halpin, Halpin, Hanania, Hanania, Hanania, Higgins, Horstman, Hunjan, Hunjan, Hunjan, Jones, Jones, Jones, Jones, Jones, Jones, Jones, Jones, Jones, Keene, Korsgaard, Kristufek, Lange, Lofdahl, Lofdahl, Lofdahl, Lofdahl, Lyseng-Williamson, Mahler, Mahler, Mahler, McGarvey, Milanowski, Nannini, Nannini, Nannini Luis, Nitschmann, Pauwels, Pauwels, Reynolds, Rodrigo, Rodrigo, Spencer, Spencer, Spencer, Spencer, Spencer, Spencer, Spencer, Spencer, Spencer, Szafranski, Vestbo, Vestbo, Vestbo, Vestbo, Vestbo, Yang   +105 more
core   +2 more sources

Treatment guided by fractional exhaled nitric oxide in addition to standard care in 6- to 15-year-olds with asthma: the RAACENO RCT

Efficacy and Mechanism Evaluation, 2022
Background: The role of fractional exhaled nitric oxide in guiding asthma treatment in children is uncertain. Objective: To compare treatment guided by both fractional exhaled nitric oxide and symptoms (intervention) with treatment guided by symptoms ...
Steve Turner, Seonaidh Cotton, Jessica Wood, Victoria Bell, Edwin-Amalraj Raja, Neil W Scott, Heather Morgan, Louisa Lawrie, David Emele, Charlotte Kennedy, Graham Scotland, Shona Fielding, Graeme MacLennan, John Norrie, Mark Forrest, Erol Gaillard, Johan de Jongeste, Marielle Pijnenburg, Mike Thomas, David Price   +19 more
doaj   +1 more source

Management of exacerbations of COPD [PDF]

Medicine, 2003
Exacerbations of chronic obstructive pulmonary disease (COPD) are an important cause of morbidity and mortality in the condition, and their incidence increases with its severity. Some patients suffer frequent exacerbations leading to hospital admission, with considerable impact on their quality of life and activities of daily living. COPD exacerbations
Seemungal, Terence, Wedzicha, Jadwiga A
openaire   +2 more sources

The Laboratory-Based Intermountain Validated Exacerbation (LIVE) Score Identifies Chronic Obstructive Pulmonary Disease Patients at High Mortality Risk. [PDF]

, 2018
Background: Identifying COPD patients at high risk for mortality or healthcare utilization remains a challenge. A robust system for identifying high-risk COPD patients using Electronic Health Record (EHR) data would empower targeting interventions aimed ...
Arjomandi, Mehrdad, Blagev, Denitza P, Carey, Kyle A, Churpek, Matthew M, Collingridge, Dave S, Horne, Benjamin D, Mularski, Richard A, Press, Valerie G, Rea, Susan, Zeng, Siyang   +9 more
core   +1 more source

Diaphragm Ultrasound is an Imaging Biomarker that Distinguishes Exacerbation Status from Stable Chronic Obstructive Pulmonary Disease

International Journal of COPD, 2022
Tai Joon An,1 Yeun Jie Yoo,2 Jeong Uk Lim,1 Wan Seo,3 Chan Kwon Park,1 Chin Kook Rhee,4 Hyoung Kyu Yoon1 1Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Yeouido St.
An TJ, Yoo YJ, Lim JU, Seo W, Park CK, Rhee CK, Yoon HK   +6 more
doaj  

Role of mean platelet volume in patients with chronic obstructive pulmonary disease

The Egyptian Journal of Bronchology, 2016
Background and objective Stable chronic obstructive pulmonary disease (COPD) is associated with low-grade systemic inflammation as demonstrated by an increase in blood leukocytes, acute-phase proteins such as C-reactive protein, and inflammatory ...
Eman R. Ali
doaj   +1 more source